Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Clinical trial NCT01981551 · COMPLETED
Trial details
- NCT number
- NCT01981551
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-31
- Primary completion
- 2018-12-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.